Arrayus is a cutting-edge medical technology company based in Burlington, Canada, focused on developing a non-invasive focused ultrasound therapy platform that aims to revolutionize cancer treatment. Their transformative technology offers a non-invasive alternative to traditional surgery, providing rapid recovery and enhanced treatment efficacy for patients with oncological disorders.
Led by founder and scientific visionary Dr. Kullervo Hynynen, Arrayus combines focused ultrasound therapy with MRI image guidance to deliver fast, safe, and effective treatment options for a range of oncological diseases. With a dedicated team of experts, Arrayus is committed to advancing focused ultrasound therapies through strategic research and collaboration partnerships, paving the way for a new era in cancer treatment.
Generated from their website